127 related articles for article (PubMed ID: 685736)
21. [The effect of estrogen and, sex-steroids and thyroid hormone preparation on bone mineral density in senile osteoporosis--a comparative study of the effect of 1 alpha-hydroxycholecalciferol (1 alpha-OHD3) on senile osteoporosis].
Shiraki M; Orimo H
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):84-95. PubMed ID: 1645679
[TBL] [Abstract][Full Text] [Related]
22. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
[TBL] [Abstract][Full Text] [Related]
23. [Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma].
Ememl'ianov AV; Shevelev SE; Murzin BA; Amosov VI
Ter Arkh; 1999; 71(11):68-9. PubMed ID: 10626343
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis.
Davies M; Mawer EB; Adams PH
J Clin Endocrinol Metab; 1977 Aug; 45(2):199-208. PubMed ID: 195972
[TBL] [Abstract][Full Text] [Related]
25. 1 alpha-Hydroxycholecalciferol and calcium deficiency osteoporosis in adult rats.
Lindholm TS
Scand J Rheumatol; 1979; 8(4):257-63. PubMed ID: 534319
[TBL] [Abstract][Full Text] [Related]
26. 1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.
Fournier A; Morinière PH; Oprisiu R; Yverneau-Hardy P; Westeel PF; Mazouz H; el Esper N; Ghazali A; Boudailliez B
Nephron; 1995; 71(3):254-83. PubMed ID: 8569975
[TBL] [Abstract][Full Text] [Related]
27. 1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol.
Chan JC; Oldham SB; Holick MF; DeLuca HF
JAMA; 1975 Oct; 234(1):47-52. PubMed ID: 1174223
[TBL] [Abstract][Full Text] [Related]
28. [The measurements of parathyroid hormones in sera of elderly osteoporotic patients with serum high alkaline phosphatase activity].
Torizumi K; Aibata H; Taniguchi Y; Kiji S; Ueyoshi A; Shimizu E; Okamoto Y; Ota K
Radioisotopes; 1988 Mar; 37(3):163-5. PubMed ID: 3387605
[TBL] [Abstract][Full Text] [Related]
29. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
[TBL] [Abstract][Full Text] [Related]
30. Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3.
Orimo H; Shiraki M; Hayashi T; Nakamura T
Bone Miner; 1987 Oct; 3(1):47-52. PubMed ID: 3505192
[TBL] [Abstract][Full Text] [Related]
31. Long-term experience of alfacalcidol in renal osteodystrophy.
Sharman VL; Brownjohn AM; Goodwin FJ; Hately W; Manning RM; O'Riordan JH; Papapoulos SE; Marsh FP
Q J Med; 1982; 51(203):271-8. PubMed ID: 7146311
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial of intermittent versus continuous oral alfacalcidol treatment of hyperparathyroidism in end-stage renal disease.
Tarrass F; Yazidi A; Sif H; Zamd M; Benghanem MG; Ramdani B
Clin Nephrol; 2006 Jun; 65(6):415-8. PubMed ID: 16792136
[TBL] [Abstract][Full Text] [Related]
33. 1 alpha-hydroxyvitamin D3 in intestinal calcium malabsorption. A pilot study.
Hylander E; Jarnum S
Scand J Gastroenterol; 1980; 15(4):443-8. PubMed ID: 7433906
[TBL] [Abstract][Full Text] [Related]
34. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.
Neer RM; Holick MF; DeLuca HF; Potts JT
Metabolism; 1975 Dec; 24(12):1403-13. PubMed ID: 1196134
[TBL] [Abstract][Full Text] [Related]
35. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
Bordier P; Zingraff J; Gueris J; Jungers P; Marie P; Pechet M; Rasmussen H
Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
[TBL] [Abstract][Full Text] [Related]
36. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
Gallagher JC; Riggs BL; DeLuca HF
J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
38. Phosphate and 1alpha-hydroxyvitamin D3 therapy in haemodialysis patients.
Davison AM; Peacock M; Walker GS; Marshall DH; McLaughlin MS; Robinson PJ
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():91s-99s. PubMed ID: 606431
[No Abstract] [Full Text] [Related]
39. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.
Klein RG; Arnaud SB; Gallagher JC; Deluca HF; Riggs BL
J Clin Invest; 1977 Jul; 60(1):253-9. PubMed ID: 874087
[TBL] [Abstract][Full Text] [Related]
40. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
Weber K; Goldberg M; Stangassinger M; Erben RG
J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
